Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Medivation's Xtandi Easily Outperforms Casodex In Key Trial

 

Medivation's Xtandi Easily Outperforms Casodex In Key Trial

2015-01-23 22:10:48| Biotech - Topix.net

Patients taking Xtandi had a median PFS of 15.7 months compared to 5.8 months in the Casodex group. I have written many articles about Medivation and why I believe their prostate cancer drug Xtandi is going to be a multi-billion dollar drug.

Tags: key trial easily outperforms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Unpaid carers being forced to repay 250m to DWP 18.05 Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook 18.05 Eastern North Pacific Tropical Weather Outlook 18.05 Atlantic Tropical Weather Outlook More »